{"id":"https://openalex.org/W2411265745","doi":null,"title":"Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd).","display_name":"Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd).","publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W2411265745","mag":"2411265745","pmid":"https://pubmed.ncbi.nlm.nih.gov/27254403"},"language":"en","primary_location":{"id":"pmh:oai:actaspsiquiatria.es:article/913","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/913","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/913/1464","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://actaspsiquiatria.es/index.php/actas/article/download/913/1464","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034044460","display_name":"Cecilio \u00c1lamo","orcid":"https://orcid.org/0000-0001-7652-7931","observed_orcids":["https://orcid.org/0000-0001-7652-7931"]},"institutions":[{"id":"https://openalex.org/I189268942","display_name":"Universidad de Alcal\u00e1","ror":"https://ror.org/04pmn0e78","country_code":"ES","type":"education","lineage":["https://openalex.org/I189268942"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cecilio Alamo","raw_affiliation_strings":["Department of Biomedical Sciences. School of Medicine and Health Sciences. University of Alcal\u00e1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences. School of Medicine and Health Sciences. University of Alcal\u00e1","institution_ids":["https://openalex.org/I189268942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065965614","display_name":"Francisco Javier Lopez-Munoz","orcid":"https://orcid.org/0000-0002-5188-6038","observed_orcids":["https://orcid.org/0000-0002-5188-6038"]},"institutions":[{"id":"https://openalex.org/I4210086614","display_name":"Research Institute Hospital 12 de Octubre","ror":"https://ror.org/002x1sg85","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210086614"]},{"id":"https://openalex.org/I59946547","display_name":"Camilo Jos\u00e9 Cela University","ror":"https://ror.org/03f6h9044","country_code":"ES","type":"education","lineage":["https://openalex.org/I59946547"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francisco L\u00f3pez-Mu\u00f1oz","raw_affiliation_strings":["School of Health Sciences and Chair of Genomic Medicine, University Camilo Jos\u00e9 Cela Unit of Neuropsychopharmacology, Hospital 12 de Octubre Research Institute i+12"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Health Sciences and Chair of Genomic Medicine, University Camilo Jos\u00e9 Cela Unit of Neuropsychopharmacology, Hospital 12 de Octubre Research Institute i+12","institution_ids":["https://openalex.org/I4210086614","https://openalex.org/I59946547"]}]},{"author_position":"last","author":{"id":null,"display_name":"Javier S\u00e1nchez-Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier S\u00e1nchez-Garc\u00eda","raw_affiliation_strings":["Hospital CRTD. Proyecto Hombre"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital CRTD. Proyecto Hombre","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3797,"has_fulltext":true,"cited_by_count":32,"citation_normalized_percentile":{"value":0.79862008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"44","issue":"3","first_page":"107","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/guanfacine","display_name":"guanfacine","score":0.9089999794960022},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9179999828338623},{"id":"https://openalex.org/keywords/alpha2a-adrenergic-receptor","display_name":"alpha2A-adrenergic receptor","score":0.9480000138282776},{"id":"https://openalex.org/keywords/postsynaptic-mechanisms","display_name":"postsynaptic mechanisms","score":0.8259999752044678},{"id":"https://openalex.org/keywords/prefrontal-cortex","display_name":"prefrontal cortex","score":0.9070000052452087},{"id":"https://openalex.org/keywords/camp-signaling","display_name":"cAMP signaling","score":0.7689999938011169},{"id":"https://openalex.org/keywords/hcn-channels","display_name":"HCN channels","score":0.9290000200271606},{"id":"https://openalex.org/keywords/dendritic-spine-maturation","display_name":"dendritic spine maturation","score":0.8550000190734863},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.8029999732971191},{"id":"https://openalex.org/keywords/psychostimulants","display_name":"psychostimulants","score":0.7450000047683716},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":0.7170000076293945},{"id":"https://openalex.org/keywords/working-memory","display_name":"working memory","score":0.7440000176429749},{"id":"https://openalex.org/keywords/attention","display_name":"attention","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C2780815205","wikidata":"https://www.wikidata.org/wiki/Q5613599","display_name":"Guanfacine","level":3,"score":0.8675203919410706},{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.8405723571777344},{"id":"https://openalex.org/C197341189","wikidata":"https://www.wikidata.org/wiki/Q863533","display_name":"Postsynaptic potential","level":3,"score":0.7727606892585754},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.6693437099456787},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5374295115470886},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.49226513504981995},{"id":"https://openalex.org/C2781195155","wikidata":"https://www.wikidata.org/wiki/Q18680","display_name":"Prefrontal cortex","level":3,"score":0.48356887698173523},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.4550500810146332},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3763818144798279},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3139798939228058},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29223912954330444},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.27731451392173767},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.24172845482826233},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.16844725608825684},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.15902981162071228},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1490449607372284},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.13523909449577332},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.06329372525215149}],"mesh":[{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016316","descriptor_name":"Guanfacine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016316","descriptor_name":"Guanfacine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D058647","descriptor_name":"Adrenergic alpha-2 Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D058647","descriptor_name":"Adrenergic alpha-2 Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmh:oai:actaspsiquiatria.es:article/913","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/913","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/913/1464","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:27254403","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27254403","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Actas espanolas de psiquiatria","raw_type":"Journal Article"},{"id":"mag:2411265745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27254403","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:actaspsiquiatria.es:article/913","doi":null,"is_oa":true,"landing_page_url":"https://actaspsiquiatria.es/index.php/actas/article/view/913","pdf_url":"https://actaspsiquiatria.es/index.php/actas/article/download/913/1464","source":{"id":"https://openalex.org/S167709542","display_name":"Actas Espa\u00f1olas de Psiquiatr\u00eda","issn_l":"1139-9287","issn":["1139-9287","1578-2735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4365328534","host_organization_name":"Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor","host_organization_lineage":["https://openalex.org/P4365328534"],"host_organization_lineage_names":["Fundaci\u00f3n Juan Jos\u00e9 L\u00f3pez-Ibor"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1139-9287","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2411265745.pdf","grobid_xml":"https://content.openalex.org/works/W2411265745.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7217687646","https://openalex.org/W4313199992","https://openalex.org/W2179646396","https://openalex.org/W7167589043","https://openalex.org/W1972551153","https://openalex.org/W4390653395","https://openalex.org/W3160092234","https://openalex.org/W3092711429","https://openalex.org/W4385267389","https://openalex.org/W2917588909"],"abstract_inverted_index":{"The":[0],"treatment":[1,56],"of":[2,9,57,75,84,87,91,105,113,117,120,145],"ADHD":[3],"has":[4,40],"focused":[5],"on":[6,30,149],"the":[7,35,55,73,82,85,88,92,106,114,121,150],"use":[8],"psychostimulants":[10,138],"drugs":[11],"such":[12,23,130],"as":[13,24,50,131],"methylphenidate":[14],"or":[15,19,139],"amphetamine":[16],"and":[17,77,100,111,133],"derivatives,":[18],"not":[20,43],"stimulants":[21],"agents,":[22],"atomoxetine.":[25],"These":[26],"agents":[27],"act":[28],"mainly":[29],"catecholaminergic":[31],"presynaptic":[32],"mechanisms.":[33],"Recently":[34],"European":[36],"Medicines":[37],"Agency":[38],"(EMA)":[39],"approved":[41],"another":[42],"psychostimulant":[44],"drug,":[45],"guanfacine":[46,141],"extended":[47],"release":[48],"(ER),":[49],"a":[51],"new":[52],"option":[53],"to":[54],"ADHD,":[58],"which":[59],"acts":[60],"at":[61],"postsynaptic":[62,66,146],"level.":[63],"Guanfacine":[64],"stimulates":[65],"alfa-2A":[67,148],"adrenergic":[68],"receptors":[69,108,147],"so":[70],"it":[71],"inhibits":[72],"production":[74],"cAMP":[76],"closes":[78],"HCN":[79],"channels":[80],"enhancing":[81],"effectiveness":[83],"signal":[86],"pyramidal":[89,118],"neurons":[90,119],"prefrontal":[93],"cortex":[94],"(PFC),":[95],"thus":[96],"improving":[97],"working":[98],"memory":[99],"attention.":[101],"In":[102,135],"addition,":[103],"stimulation":[104,144],"alpha-2A":[107],"promotes":[109],"growth":[110],"maturation":[112],"dendritic":[115],"spines":[116],"medial":[122],"PFc,":[123],"that":[124],"are":[125],"associated":[126],"with":[127,137],"brain":[128],"function":[129],"learning":[132],"memory.":[134],"contrast":[136],"atomoxetine,":[140],"mimics":[142],"noradrenaline":[143],"PFC.":[151]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}